Elevance Health (ELV) Positioned for Long-Term Margin Improvement Amid Medium-Term Challenges

3 weeks ago 10

Soumya Eswaran

Tue, April 28, 2026 astatine 9:48 AM CDT 3 min read

Hotchkis & Wiley, an concern absorption company, released its first-quarter 2026 capitalist missive for the “Hotchkis & Wiley Large Cap Fundamental Value Fund.” A transcript of the missive tin beryllium downloaded here. In Q1 2026, the S&P 500 Index declined by -4.4%, driven by geopolitical uncertainty and AI concern themes. Brent crude lipid surged implicit 100% owed to U.S.-Israel strikes connected Iran, benefiting the vigor sector, which outperformed significantly. Value stocks surpassed growth, with the Russell 1000 Value Index gaining +2.1% compared to -9.8% for the Growth Index. However, the Hotchkis & Wiley Large Cap Fundamental Value Fund lagged, returning 0.36% vs. 2.10% for the Russell 1000 Value Index, driven by its overweight vulnerability successful bundle and wellness insurers. However, the vigor holdings, which returned +49%, were the portfolio's apical performers. In addition, delight cheque the Fund’s apical 5 holdings to cognize its champion picks successful 2026.

In its first-quarter 2026 capitalist letter, Hotchkis & Wiley Large Cap Fundamental Value Fund highlighted stocks specified arsenic Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is simply a wellness benefits institution that detracted from the Strategy’s show successful the quarter. On April 27, 2026, Elevance Health, Inc. (NYSE:ELV) closed astatine $356.13 per share. One-month instrumentality of Elevance Health, Inc. (NYSE:ELV) was 21.65%, and its shares mislaid 13.91% implicit the past 52 weeks. Elevance Health, Inc. (NYSE:ELV) has a marketplace capitalization of $77.34 billion.

Hotchkis & Wiley Large Cap Fundamental Value Fund stated the pursuing regarding Elevance Health, Inc. (NYSE:ELV) successful its Q1 2026 capitalist letter:

"Elevance Health, Inc. (NYSE:ELV) is 1 of the largest wellness insurers, yet it trades astatine a discount to the broader marketplace contempt being a precocious prime concern that grows faster than GDP and returns a important information of its currency to shareholders. Q1 show was weak, driven by disappointing FY26 guidance amid declining Medicaid enrollment and level Medicare reimbursement rates projected by the Trump administration. We presumption these pressures arsenic medium-term sound and judge Elevance has the quality to amended margins implicit clip done payment adjustments and/or higher premiums."

Truist Cuts Elevance Health (ELV) Price Target, Keeps Bullish View connected Healthcare Services

Elevance Health, Inc. (NYSE:ELV) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 78 hedge money portfolios held Elevance Health, Inc. (NYSE:ELV) astatine the extremity of the 4th quarter, compared to 82 successful the erstwhile quarter. While we admit the imaginable of Elevance Health, Inc. (NYSE:ELV) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article